Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Fentanyl
Abstral
Routinely available
SMC (534/09)
26/05/2010
Indication
Management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. See link to SMC advice for full details of restriction.
Therapeutic Area
Central nervous system
Status Description
Routinely available
Formulation
100, 200, 300, 400, 600 and 800 microgram sublingual tablets
Comments
May 2010 - Added to the Additional List, for Specialist Initiation.
Link to Advice
Advice Published
09/02/2009
SMC Submission Type
Abbreviated
SMC Status
Restricted